β-Blockers Show No Added Benefit After MI With Preserved LVEF

A meta-analysis of recent clinical trials evaluating β-blockers as treatment for patients with acute myocardial infarction (MI) and preserved left ventricular ejection fraction (LVEF) found this treatment did not provide any additional benefits…